Lightcast

Lightcast, founded in 2019, is a pioneering force within the Biotechnology sector. The company, based in the United Kingdom, is revolutionizing cellular analysis through its novel droplet-based platform, characterized by the slogan, "Profiling function, cell by cell."

This scalable and flexible platform distinguishes itself from traditional microfluidic methods by offering an extensive range of assay capabilities. It enables precise control over droplet parameters such as number, occupancy, location, and movement, thereby enhancing translational and basic research applications. Crucially, it also streamlines development workflows for drugs, therapeutics, and applied biologics.

In its latest financial milestone, Lightcast secured a £38.00M Series B investment on 17 August 2023. This round saw participation from notable investors including Arch Venture Partners, Illumina Ventures, Longwall Ventures, MERL Ventures Fund, ND Capital, and OMX Ventures. The investment signals robust confidence in Lightcast's innovative approach and growth potential.